Fortschr Neurol Psychiatr 2015; 83(02): 109-122
DOI: 10.1055/s-0034-1398932
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York

Liquordiagnostik bei erregerbedingten neurologischen Erkrankungen

Cerebrospinal Fluid Diagnostics for Neuroinfectious Diseases
A. Spreer
1   Klinik für Neurologie, Universitätsmedizin Göttingen
,
R. Nau
2   Institut für Neuropathologie, Universitätsmedizin Göttingen
3   Abteilung Geriatrie, Evangelisches Krankenhaus Göttingen-Weende
› Author Affiliations
Further Information

Publication History

Publication Date:
27 February 2015 (online)

Zusammenfassung

Die Analytik des Liquor cerebrospinalis ist von zentraler Bedeutung in der frühen Diagnosestellung erregerbedingter neurologischer Erkrankungen. Neben der Bestimmung grundlegender liquoranalytischer Parameter wie Zellzahl, Proteine und Laktat, ist die gezielte Suche nach Erregern bakterieller, viraler oder pilzbedingter Infektionen des ZNS entscheidend. Dies kann direkt mittels mikrobiologischer Spezialfärbungen, Kulturmethoden, Nukleinsäure- oder Antigennachweis erfolgen oder indirekt serologisch im Blut oder mittels Nachweis einer erregerspezifischen Antikörpersynthese im Liquor. Neben der Vermittlung von Grundlagen der klinischen Liquordiagnostik soll dieser Fortbildungsartikel den Blick für die speziellen Aspekte der Erregerdiagnostik schärfen. Auf diese Weise soll ermöglicht werden, durch konkrete Fragestellungen an das Labor eine zielgerichtete Analytik zu veranlassen und deren Ergebnisse kritisch zu interpretieren, um dem Patienten die bestmögliche Behandlung zukommen lassen zu können.

Abstract

Cerebrospinal fluid analysis is of prime importance to establish an early diagnosis of central nervous system infections. Beside the basic diagnostics containing CSF white cell count, lactate concentration and protein analysis, the targeted search for agents of bacterial, viral or fungal CNS infectious diseases is essential. Decisive methods are bacterial and fungal staining techniques, microbiological culture methods, nucleic acid amplification and antigen detection methods or indirect identification of pathogens by serologic testings including the determination of pathogen-specific intrathecal immunoglobulin synthesis. Besides imparting basic principles of cerebrospinal fluid analysis, this article focuses on special aspects of detection of infectious agents. Well-directed questions and a close communication between clinician and laboratory allow optimal diagnostic analysis for successful confirmation of the diagnosis and for optimal treatment of the patient.

 
  • Literatur

  • 1 Quincke H. Die Lumbalpunction des Hydrocephalus. Berliner klinische Wochenschrift 1891; 891: 929-933
  • 2 Schut ES, de Gans J, van de Beek D. Community-acquired bacterial meningitis in adults. Pract Neurol 2008; 8: 8-23
  • 3 Shem S. The House of God: Delta Trade Paperbacks. 1978;
  • 4 Woitalla D, Otto M, von Stuckrad-Barre S et al. Diagnostische Liquorpunktion. In: Diener H, Weimar C, eds Leitlinien für Diagnostik und Therapie in der Neurologie. 5. ed. Stuttgart: Thieme; 2012: 1017-1023
  • 5 Carson D, Serpell M. Choosing the best needle for diagnostic lumbar puncture. Neurology 1996; 47: 33-37
  • 6 Djukic M, Schulz D, Schmidt H et al. Cerebrospinal fluid findings in geriatric patients from 2008 to 2011. Z Gerontol Geriatr 2013; 46: 353-357
  • 7 Popp J, Riad M, Freymann K et al. Diagnostic lumbar puncture performed in the outpatient setting of a memory clinic. Frequency and risk factors of post-lumbar puncture headache. Nervenarzt 2007; 78: 547-551
  • 8 Anforderungen an die Hygiene bei Punktionen und Injektionen – Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention beim Robert Koch-Institut. Bundesgesundheitsblatt 2011; 54: 1135-1144
  • 9 Petereit H, Sindern E, Wick M. Leitlinien der Liquordiagnostik und Methodenkatalog der Deutschen Gesellschaft für Liquordiagnostik und Klinische Neurochemie. Heidelberg: Springer Medizin; 2007
  • 10 Kuntz KM, Kokmen E, Stevens JC et al. Post-lumbar puncture headaches: experience in 501 consecutive procedures. Neurology 1992; 42: 1884-1887
  • 11 Nau R. Liquordiagnostik bei bakteriellen ZNS-Erkrankungen. In: Zettl UK, Lehmitz R, Mix E, eds, Klinische Liquordiagnostik. 2 ed. Berlin: de Gruyter; 2005: 301-314
  • 12 Wildemann B, Oschmann P, Reiber H. Neurologische Labordiagnostik. Stuttgart: Thieme; 2006
  • 13 Kleine T. Notfall-Programm. In: Zettl UK, Lehmitz R, Mix E, eds Klinische Liquordiagnostik. 2. ed. Berlin: de Gruyter; 2005: 127-134
  • 14 Tumani H, Kluge H. Anatomie und Physiologie des Liquorsystems. In: Zettl UK, Lehmitz R, Mix E, eds Klinische Liquordiagnostik. 2. ed. Berlin: de Gruyter; 2005: 39-55
  • 15 Reiber H. Flow rate of cerebrospinal fluid (CSF)--a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J Neurol Sci 1994; 122: 189-203
  • 16 Andersson M, Alvarez-Cermeno J, Bernardi G et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 1994; 57: 897-902
  • 17 Wurster U, Stachan R, Windhagen A et al. Reference values for standard cerebrospinal fluid examinations in multiple sclerosis. Results from 99 healthy volunteers. In: ECMID:Multiple Sclerosis. 2006: 228
  • 18 Gray LD, Fedorko DP. Laboratory diagnosis of bacterial meningitis. Clin Microbiol Rev 1992; 5: 130-145
  • 19 La Scolea Jr LJ, Dryja D. Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol 1984; 19: 187-190
  • 20 Tunkel AR, Hartman BJ, Kaplan SL et al. Practice guidelines for the management of bacterial meningitis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2004; 39: 1267-1284
  • 21 van de Beek D, de Gans J, Spanjaard L et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351: 1849-1859
  • 22 Nigrovic LE, Malley R, Macias CG et al. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics 2008; 122: 726-730
  • 23 Kennedy DH, Fallon RJ. Tuberculous meningitis. JAMA 1979; 241: 264-268
  • 24 Perfect JR. Cryptococcus neoformans. In: Mandell GL, Bennett JE, Dolin R, eds Principles and Practice of Infectious Diseases. Philadelphia, Pennsylvania: Elsevier; 2005: 2997-3011
  • 25 Marchetti O, Lamoth F, Mikulska M et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012; 47: 846-854
  • 26 Portegies P, Solod L, Cinque P et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol 2004; 11: 297-304
  • 27 Arendt G, Eggers C, Furrer H et al. Diagnostik und Therapie HIV-1-assoziierter neurologischer Erkrankungen. In: Diener H, Weimar C, eds Leitlinien für Diagnostik und Therapie in der Neurologie. 5. ed. Stuttgart: Thieme; 2012: 560-569
  • 28 Bennett JE, Hasenclever HF, Tynes BS. Detection of Cryptococcal Polysaccharide in Serum and Spinal Fluid: Value in Diagnosis and Prognosis. Trans Assoc Am Physicians 1964; 77: 145-150
  • 29 Debiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev 2004; 17: 903-925 , table of contents
  • 30 Chaudhuri A, Martinez-Martin P, Kennedy PG et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS Task Force on acute bacterial meningitis in older children and adults. Eur J Neurol 2008; 15: 649-659
  • 31 Greisen K, Loeffelholz M, Purohit A et al. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol 1994; 32: 335-351
  • 32 Srinivasan L, Pisapia JM, Shah SS et al. Can broad-range 16S ribosomal ribonucleic acid gene polymerase chain reactions improve the diagnosis of bacterial meningitis? A systematic review and meta-analysis. Ann Emerg Med 2012; 60: 609-620 e602
  • 33 Steiner I, Schmutzhard E, Sellner J et al. EFNS-ENS guidelines for the use of PCR technology for the diagnosis of infections of the nervous system. Eur J Neurol 2012; 19: 1278-1291
  • 34 Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991; 37: 1153-1160
  • 35 Diener H, Weimar C. Leitlinien für Diagnostik und Therapie in der Neurologie. 5. ed. Stuttgart: Thieme; 2012
  • 36 Zettl UK, Lehmitz R, Mix E. Klinische Liquordiagnostik. 2. ed. Berlin: de Gruyter; 2005
  • 37 Sussmuth SD, Brettschneider J, Spreer A et al. Current cerebrospinal fluid diagnostics for pathogen-related diseases. Nervenarzt 2013; 84: 229-244
  • 38 Proulx N, Frechette D, Toye B et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005; 98: 291-298
  • 39 Bonadio WA. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J 1992; 11: 423-431
  • 40 McGrath N, Anderson NE, Croxson MC et al. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 1997; 63: 321-326
  • 41 Raschilas F, Wolff M, Delatour F et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2002; 35: 254-260
  • 42 Tyler KL. Herpes simplex virus infections of the central nervous system: encephalitis and meningitis, including Mollaret’s. Herpes 2004; 11 (Suppl. 02) 57A-64A
  • 43 Aurelius E, Johansson B, Skoldenberg B et al. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 1991; 337: 189-192
  • 44 Revello MG, Baldanti F, Sarasini A et al. Quantitation of herpes simplex virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis by the polymerase chain reaction. Clinical and diagnostic virology 1997; 7: 183-191
  • 45 Weil AA, Glaser CA, Amad Z et al. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2002; 34: 1154-1157
  • 46 Rauer S, Kaiser R, Kölmel HW et al. Neuroborreliose. In: Diener H, Weimar C, eds Leitlinien für Diagnostik und Therapie in der Neurologie. 5. ed. Thieme: 2012: 513-522
  • 47 Mygland A, Ljostad U, Fingerle V et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17: 8-16, e11 – e14
  • 48 Spreer A, Djukic M, Nau R et al. Update Neuroborreliose – Neues und Bewährtes. Aktuelle Neurologie 2013; 40: 7-15
  • 49 Djukic M, Schmidt-Samoa C, Lange P et al. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol 2011; 259: 630-636
  • 50 Schmidt C, Plate A, Angele B et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011; 76: 1051-1058
  • 51 Kaiser R, Holzmann H. Laboratory findings in tick-borne encephalitis – correlation with clinical outcome. Infection 2000; 28: 78-84
  • 52 Kaiser R, Archelos-Garcia J, Jilg W et al. Frühsommer-Meningoenzephalitis (FSME). In: Diener H, Weimar C, eds Leitlinien für Diagnostik und Therapie in der Neurologie. 5. ed. Stuttgart: Thieme; 2012: 554-559
  • 53 Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001; 184: 101-122
  • 54 Nau R, Behnke-Mursch J, Eiffert H et al. Hirnabszess. In: Diener H, Weimar C, eds, Leitlinien für Diagnostik und Therapie in der Neurologie. 5. ed. Stuttgart: Thieme; 2012: 505-512
  • 55 Bitsch A, Nau R, Hilgers R et al. Focal neurologic deficits in infective endocarditis and other septic diseases. Acta Neurol Scnad 1996; 94: 279-286